I think often in life, the unsexy stuff is where the real rubber hits the road. And so I think that's the sort of holy grail on the drug design side. Swinging back to the provisioning side, it feels like what you're saying, there's a lot of the problem with the 25% of GDP going to this industry as a lot of it is just kind of mucked up in old systems. What AI can do is kind of not that sexy, but super useful of being able to take unstructured data and put it into usable form.
The Sunday Times’ tech correspondent Danny Fortson brings on Vijay Pande, head of Andreessen Horowitz’s $1.5bn bio fund, to talk about how artificial intelligence is impacting healthcare (3:30), tools that “understand” biology (8:50), trying to eliminate cancer (12:50), trying to get techie founders to get into healthcare (14:25), America’s plunging life expectancy (18:00), the (potential) end of radiology (21:10), AI’s “hallucination" problem in healthcare (25:55), the future of therapy (29:00), putting healthcare on the Moore’s Law curve (33:10), using automation to slash the industry’s costs and inefficiencies (37:30), the next trillion dollar company (40:00), if capitalism is the best way to crack healthcare (45:40), and solving the billing problem(48:35).
Hosted on Acast. See acast.com/privacy for more information.